@article{2dab751bd3184e0abc03aa6b1caa07a5,
title = "The FIDELIO Study Podcast",
keywords = "Chronic kidney disease, Diabetic kidney disease, FIDELIO, Finerenone, Mineralocorticoid receptor antagonist, Type 2 diabetes",
author = "Robert Toto and George Bakris",
note = "Funding Information: The podcast and the journal{\textquoteright}s Rapid Service Fee were funded by Bayer Corporation. Medical writing assistance was provided by John Bilbruck of Envision Pharma Group and was funded by Bayer Corporation. Envision Pharma Group{\textquoteright}s services complied with international guidelines for Good Publication Practice (GPP3). All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. Dr Toto and Dr Bakris participated substantively in the drafting, writing, critical revision, and approval of the final versions of the audio podcast and accompanying transcript. Dr Toto is a consultant for Akebia, AstraZeneca, Amgen, Bayer, Boehringer-Ingelheim, Chinook Pharma, Medscape, Novo Nordisk Otsuka, Reata, and Relypsa/Vifor Pharma. Dr Bakris is a consultant for Merck, Bayer, KBP Biosciences, Ionis, Alnylam, Astra Zeneca, Quantum Genomics, Horizon, Novo Nordisk, Dia Medica, and inRegen, and has received research support and/or been a member of steering committees of trials for Bayer, Quantum Genomics, Alnylam, Novo Nordisk, and Dia Medica. This article does not contain any new studies with human participants or animals performed by any of the authors. Please note, contrary to the journal{\textquoteright}s standard single-blind peer review process, as a podcast this article underwent review by a member of the journal{\textquoteright}s Editorial Board. Funding Information: The podcast and the journal{\textquoteright}s Rapid Service Fee were funded by Bayer Corporation. ",
year = "2022",
month = may,
doi = "10.1007/s13300-022-01249-5",
language = "English (US)",
volume = "13",
pages = "823--828",
journal = "Diabetes Therapy",
issn = "1869-6953",
publisher = "Springer Publishing Company",
number = "5",
}